乳房保乳治疗史患者自体与假体重建的失败率比较
本研究回顾性分析2017年1月至2025年3月有保乳治疗(BCT)史的乳房重建患者,采用倾向评分匹配比较自体与假体重建结局。匹配后BCT史患者并发症高于无放疗对照组,尤其假体重建;在BCT患者中,自体重建的失败率显著低于假体重建(2.2% vs 24.4%,p<0.001)。
要点
- 有BCT史患者乳房重建术后并发症风险升高,假体重建尤为明显
- BCT史患者中自体重建失败率显著低于假体重建(2.2% vs 24.4%)
- 条件允许时,BCT史患者应优先考虑自体组织重建
核心结论
- 有BCT史与乳房重建术后并发症增加相关,尤其是假体重建。
- 在BCT患者中,自体重建的失败率低于假体重建,条件允许时应强烈考虑自体重建。
研究设计与样本
- 回顾性研究,纳入2017年1月至2025年3月有BCT史并接受自体或假体重建的患者。
- 采用倾向评分匹配,将BCT患者与无放疗对照组比较,并比较自体与假体重建结局。
主要发现
- 匹配的自体队列中,50例BCT患者与200例无放疗患者匹配,BCT组任何并发症发生率更高(36.0% vs 20.0%,p=0.02)。
- 匹配的假体队列中,49例BCT患者与490例无放疗患者匹配,BCT组主要、次要及任何并发症发生率均显著更高(均p≤0.001)。
- 比较自体BCT与假体BCT(各匹配45例),自体重建失败率更低(2.2% vs 24.4%,p<0.001),其他并发症相当。
临床怎么用
- 对有意愿重建且有BCT史的患者,应告知假体重建并发症和失败风险较高。
- 在BCT史患者中,若条件允许,应优先考虑自体组织重建以降低失败率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: An increasing number of women present for mastectomy and reconstruction following prior lumpectomy and irradiation, also known as breast-conserving therapy (BCT). While reconstruction after postmastectomy radiotherapy is well studied, outcomes following prior BCT remain less clearly defined. This study aimed to compare reconstructive outcomes in patients with a history of BCT. METHODS: A retrospective review of patients with autologous or implant-based reconstructions with a history of BCT between January 2017 and March 2025 was performed. Patients were compared with radiation-naïve controls and reconstructive outcomes were compared. Propensity score matching was used to minimize selection bias. Complications were categorized as major, minor, or any complication. RESULTS: In the matched autologous cohort, 50 BCT patients were matched to 200 radiation-naïve patients; those with prior BCT experienced higher rates of any complication (36.0% vs 20.0%, p=0.02), mainly caused by higher infection (8.0% vs 3.0%, p=0.2) and mastectomy skin flap necrosis (10.0% vs 3.5%, 0.07). In the matched implant-based cohort (49 BCT, 490 radiation-naïve), patients with prior BCT experienced significantly higher rates for major, minor and any complications (all p≤0.001). When comparing autologous BCT to implant-based BCT (45 matched in each), autologous reconstruction experienced lower rates of reconstruction failure (2.2% vs 24.4%, p<0.001). Other complications were comparable. CONCLUSION: A history of BCT is associated with increased postoperative complications following breast reconstruction, particularly in implant-based reconstructions. Autologous reconstruction offers lower failure rates in this population and should be strongly considered when feasible.
引用
- Nelissen SH, Elmorsi R, Schaverien MV, et al. Less reconstruction failure in autologous over implant-based breast reconstructions in patients with a history of breast conserving therapy. Plast Reconstr Surg. 2026. PMID: 42160708. doi:10.1097/PRS.0000000000013218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。